| Recruiting | N/A | 150 | Europe | Zoledronate, zoledronic acid; zolendronate, Denosumab, Dmab, Teriparatide, TPTD, Romosozumab, Romo | 424 General Military Hospital | Osteoporosis, Postmenopausal | 12/25 | 12/25 | | |
NCT06645951: Institution of an Italian Multicenter Database of Patients With Parathyroid Carcinoma or Atypical Parathyroid Adenoma |
|
|
| Not yet recruiting | N/A | 300 | Europe | | F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore | Parathyroid Gland Carcinoma, Parathyroid Gland Atypical Adenoma | 11/34 | 11/34 | | |
NCT06645899: Institution of an Italian Multicenter Database of Patients Affected by Hypoparathyroidism or Pseudohypoparathyroidism |
|
|
| Not yet recruiting | N/A | 600 | Europe | | F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore | Hypoparathyroidism, Pseudo Hypoparathyroidism | 11/34 | 11/34 | | |
EURODEC, NCT05575167: Single or Repeat Zoledronate Versus Alendronate Following Denosumab (EUROpean Denosumab Effects Consolidation Study) |
|
|
| Recruiting | N/A | 125 | Europe | Zoledronate or Alendronate, Calcium and vitamin D supplementation | 424 General Military Hospital | Osteoporosis, Postmenopausal | 11/26 | 11/26 | | |
